1. Home
  2. Search

Search

Search results

755 results found

CaptoCore resin for EV "clean-up"

Link
In collaboration with Dr. Ionita Ghiran, Dr. Alexander Ivanov, and Dr. Jennifer Jones, the MassNano core has been using CaptoCore 700 for removal of contaminants, excess dyes, and other large molecules for EV, LNP, and viral preps. Please see the following publications for more details on how resins...

About Us

Page
The Center for Patient-Derived Models for Personalized Medicine at Beth Israel Deaconess Medical Center (BIDMC) is dedicated to developing clinically relevant cancer models that advance precision oncology and translational research. We work in close collaboration with clinical teams at BIDMC to...

Published Evidence on Peripheral Atherectomy: A Meta-analysis and Systematic Literature Review of More Than 300 Original Investigations.

Publication: Journal Article
Carr, Jeffrey G, Ralf Langhoff, Brian G DeRubertis, Kristin L Hood, Prakash Krishnan, Vikram Puttaswamy, Thomas Zeller, and Eric A Secemsky. 2025. “Published Evidence on Peripheral Atherectomy: A Meta-Analysis and Systematic Literature Review of More Than 300 Original Investigations.”. Journal of the Society for Cardiovascular Angiography & Interventions 4 (11): 104009.

TTU Highplex assays Pricing

Page
2026 pricing (Data generation only/Per slide) BIDMC Ext. Academic Industry IN-DEPTH (Akoya Hu io60 & Visium HD Hu WTX all on one slide; Exc. Sequencing; Min. 2 slides) $11,270 $13,148 $16,036 IN-DEPTH (Akoya Hu io60 & CosMX Hu 6K all on one slide; Min. 2 slides) $17,800 $20,700 $26,000 Akoya CODEX...

Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with Adalimumab.

Publication: Journal Article
Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated With Less Treatment Failure in Patients With Inflammatory Bowel Disease Treated With Adalimumab.”. Digestive Diseases and Sciences.